MedPath

Astelin

ASTELIN (azelastine hydrochloride) Nasal Spray, 137 mcg IN-023S6-07 Rev. 1/09 For Intranasal Use Only

Approved
Approval ID

944349ca-7cdb-441a-8fd0-b8616857d338

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 18, 2010

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Azelastine Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-5072
Application NumberNDA020114
Product Classification
M
Marketing Category
C73594
G
Generic Name
Azelastine Hydrochloride
Product Specifications
Route of AdministrationNASAL
Effective DateNovember 29, 2010
FDA Product Classification

INGREDIENTS (2)

BENZALKONIUM CHLORIDEInactive
Quantity: 125 ug in 1 1
Code: F5UM2KM3W7
Classification: IACT
AZELASTINE HYDROCHLORIDEActive
Quantity: 137 ug in 1 1
Code: 0L591QR10I
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Astelin - FDA Drug Approval Details